UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis

Scientific reports, 2021-03, Vol.11 (1), p.5565-14, Article 5565

2021

Link zum Volltext

Verfügbarkeit prüfen

Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin

Journal of cellular and molecular medicine, 2016-04, Vol.20 (4), p.710-720

2016

Link zum Volltext

Verfügbarkeit prüfen

Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa

Scientific reports, 2017-05, Vol.7 (1), p.2102-13, Article 2102

2017

Link zum Volltext

Verfügbarkeit prüfen

Correction: Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin

PloS one, 2020-09, Vol.15 (9), p.e0238969-e0238969

2020

Link zum Volltext

Verfügbarkeit prüfen

A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss

BMC biotechnology, 2018-04, Vol.18 (1), p.21-21, Article 21

2018

Link zum Volltext

Verfügbarkeit prüfen

Fusion to Human Serum Albumin Extends the Circulatory Half-Life and Duration of Antithrombotic Action of the Kunitz Protease Inhibitor Domain of Protease Nexin 2

Cellular physiology and biochemistry, 2018-02, Vol.45 (2), p.772-782

2018

Link zum Volltext

Verfügbarkeit prüfen

Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant

Frontiers in cardiovascular medicine, 2021-03, Vol.8, p.647405

2021

Link zum Volltext

Verfügbarkeit prüfen

Phage display of the serpin alpha-1 proteinase inhibitor randomized at consecutive residues in the reactive centre loop and biopanned with or without thrombin

PloS one, 2014-01, Vol.9 (1), p.e84491-e84491

2014

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris

Regulatory peptides, 2012-04, Vol.175 (1-3), p.7-10

2012

Link zum Volltext

Verfügbarkeit prüfen

A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo

Thrombosis and haemostasis, 2009-05, Vol.101 (5), p.867

2009

Link zum Volltext

Verfügbarkeit prüfen

The M358R variant of α1-proteinase inhibitor inhibits coagulation factor VIIa

Biochemical and biophysical research communications, 2016-02, Vol.470 (3), p.710-713

2016

Link zum Volltext

Verfügbarkeit prüfen

M358R variant of Î±1-proteinase inhibitor inhibits coagulation factor VIIa

Biochemical and biophysical research communications, 2016, Vol.470, p.710-713

2016

Link zum Volltext

Verfügbarkeit prüfen

Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin

Journal of biotechnology, 2021-03, Vol.330, p.61-69

2021

Link zum Volltext

Verfügbarkeit prüfen

An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice

Thrombosis and haemostasis, 2005-12, Vol.94 (6), p.1138

2005

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity” [J. Biotechnol. 208 (2015) 54–62]

Journal of biotechnology, 2020-03, Vol.311, p.59-59

2020

Link zum Volltext

Verfügbarkeit prüfen

Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis

BMC biotechnology, 2009-03, Vol.9 (1), p.15-15

2009

Link zum Volltext

Verfügbarkeit prüfen

Cold‐stored leukoreduced whole blood: Extending the time between donation and filtration has minimal impact on in vitro quality

Transfusion (Philadelphia, Pa.), 2021-07, Vol.61 (S1), p.S131-S143

2021

Link zum Volltext

Verfügbarkeit prüfen

Cold-stored leukoreduced whole blood: no impact of extended time between donation and filtration on in vitro quality

Transfusion medicine reviews, 2021-01, Vol.35 (1), p.56-56

2021

Link zum Volltext

Verfügbarkeit prüfen

The M358R variant of α 1 -proteinase inhibitor inhibits coagulation factor VIIa

Biochemical and biophysical research communications, 2016-02, Vol.470 (3), p.710-713

2016

Link zum Volltext

Verfügbarkeit prüfen

Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis

Transfusion (Philadelphia, Pa.), 2017-03, Vol.57 (3), p.661-673

2017

Link zum Volltext

Verfügbarkeit prüfen

Extending the pre-processing holding time of whole blood beyond 48 h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma

Transfusion and apheresis science, 2018-12, Vol.57 (6), p.768-772

2018

Link zum Volltext

Verfügbarkeit prüfen

Retention of hemostatic and immunological properties of frozen plasma and COVID‐19 convalescent apheresis fresh‐frozen plasma produced and freeze‐dried in Canada

Transfusion (Philadelphia, Pa.), 2022-02, Vol.62 (2), p.418-428

2022

Link zum Volltext

Verfügbarkeit prüfen

Monovalent Fc receptor blockade by an anti–Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity

Blood, 2016-01, Vol.127 (1), p.132-138

2016

Link zum Volltext

Verfügbarkeit prüfen

Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation

Thrombosis and haemostasis, 2005-05, Vol.93 (5), p.914

2005

Link zum Volltext

Verfügbarkeit prüfen

CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor- and Complement Receptor 3-Dependent Mechanisms

The Journal of immunology (1950), 2016-04, Vol.196 (8), p.3331-3340

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis

Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin

Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa

Correction: Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin

A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss

Fusion to Human Serum Albumin Extends the Circulatory Half-Life and Duration of Antithrombotic Action of the Kunitz Protease Inhibitor Domain of Protease Nexin 2

Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant

Phage display of the serpin alpha-1 proteinase inhibitor randomized at consecutive residues in the reactive centre loop and biopanned with or without thrombin

Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris

A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo

The M358R variant of α1-proteinase inhibitor inhibits coagulation factor VIIa

M358R variant of Î±1-proteinase inhibitor inhibits coagulation factor VIIa

Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin

An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice

Corrigendum to “Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity” [J. Biotechnol. 208 (2015) 54–62]

Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis

Cold‐stored leukoreduced whole blood: Extending the time between donation and filtration has minimal impact on in vitro quality

Cold-stored leukoreduced whole blood: no impact of extended time between donation and filtration on in vitro quality

The M358R variant of α 1 -proteinase inhibitor inhibits coagulation factor VIIa

Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis

Extending the pre-processing holding time of whole blood beyond 48 h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma

Retention of hemostatic and immunological properties of frozen plasma and COVID‐19 convalescent apheresis fresh‐frozen plasma produced and freeze‐dried in Canada

Monovalent Fc receptor blockade by an anti–Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity

Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation

CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor- and Complement Receptor 3-Dependent Mechanisms

Suchergebnisse filtern